505 South Flagler Drive, Suite 1330
West Palm Beach, FL 33401
Founding Date: 2006
E-Florida Region: Southeast
Tyrogenex is focused on developing cancer therapeutics.
Tyrogenex has developed a novel, patented cancer therapeutic, X-82. The compound is a small molecule indolinone inhibitor of signaling through the growth factor receptors VEGFR and PDGFR
Therapy for cancer including advanced solid tumors.
The University of Florida and any third party content providers shall retain all worldwide rights in the intellectual property of this site including the copyright in and to its original content. You may reproduce the site content for any legal purpose with proper attribution. Attribution shall take the following form: "Materials provided by University of Florida's Sid Martin Biotechnology Incubator www.sidmartinbio.org".